Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201307069 Principal Investigator: Linette, Gerald
Title: Phase 2, Randomized, Double Blinded, Study of Nivolumab (BMS-936558) in Combination with Ipilimumab vs Ipilimumab Alone in Subjects with Previously Untreated, Unresectable or Metastatic Melanoma
Phase: II Disease Site: Melanoma, Skin
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to see if giving a research drug, called nivolumab, with ipilimumab is able to treat melanoma better than ipilimumab alone.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)